Shouichi Tateyama

Title: Shouichi Tateyama: Innovator in Pharmaceutical Chemistry

Introduction

Shouichi Tateyama is a notable inventor based in Funabashi, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative methods for producing optically active compounds. His work is essential for developing intermediates used in pharmaceuticals.

Latest Patents

Tateyama holds a patent for a "Method for producing optically active 5-hydroxy-3-ketoester." The objective of this invention is to provide a method that yields high quantities of optically active 5-hydroxy-3-ketoester compounds with high stereoselectivity. This compound is valuable as an intermediate in pharmaceutical applications. The method involves an asymmetric aldol reaction using a 1,3-diene compound in the presence of an optically active binaphthol-titanium complex, along with a substituted nitrogen-containing aromatic heterocyclic compound. This innovative approach results in a high yield of the desired compound.

Career Highlights

Shouichi Tateyama is associated with Nissan Chemical Industries Limited, where he applies his expertise in chemical processes. His work has been instrumental in advancing the production methods of pharmaceutical intermediates, contributing to the efficiency and effectiveness of drug development.

Collaborations

Tateyama has collaborated with notable colleagues such as Shinya Naitou and Yasutaka Takada. These collaborations have further enhanced the research and development efforts within the pharmaceutical sector.

Conclusion

Shouichi Tateyama's contributions to pharmaceutical chemistry through his innovative patent demonstrate his commitment to advancing the field. His work not only benefits the industry but also plays a crucial role in the development of effective pharmaceutical products.